Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.
Körper S, Weiss M, Zickler D, Wiesmann T, Zacharowski K, Corman VM, Grüner B, Ernst L, Spieth P, Lepper PM, Bentz M, Zinn S, Paul G, Kalbhenn J, Dollinger MM, Rosenberger P, Kirschning T, Thiele T, Appl T, Mayer B, Schmidt M, Drosten C, Wulf H, Kruse JM, Jungwirth B, Seifried E, Schrezenmeier H; CAPSID Clinical Trial Group.
Körper S, et al. Among authors: kirschning t.
J Clin Invest. 2021 Oct 15;131(20):e152264. doi: 10.1172/JCI152264.
J Clin Invest. 2021.
PMID: 34464358
Free PMC article.
Clinical Trial.